Duration of Adjuvant Tamoxifen Treatment

Breast Cancer Research - United Kingdom
doi 10.1186/bcr-2001-68461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Side Effects of Adjuvant Tamoxifen.

BMJ
1991English

Adjuvant Tamoxifen – Longer Against Shorter (ATLAS)

Breast Cancer Online
2006English

Duration of Adjuvant Treatment Following Radical Resection of Metastases From Gastrointestinal Stromal Tumours

Oncology Letters
Cancer ResearchOncology
2011English

Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil

Revista da Associacao Medica Brasileira
Medicine
2009English

Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

Tamoxifen — No Longer a Golden Standard for Adjuvant Therapy in the Treatment of Premenopausal Patients With Hormone-Sensitive Breast Cancer

Nowotwory
Cancer ResearchOncology
2017English

Is the Duration of Adjuvant Trastuzumab Debate Still Clinically Relevant?

The Lancet
Medicine
2019English

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2010English

Granulosa Cell Tumor of the Ovary and Antecedent of Adjuvant Tamoxifen Use for Breast Cancer

World Journal of Surgical Oncology
SurgeryOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy